<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9033">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05706675</url>
  </required_header>
  <id_info>
    <org_study_id>REC-22-02-28-02-S</org_study_id>
    <nct_id>NCT05706675</nct_id>
  </id_info>
  <brief_title>Specialized Pro-resolving Mediators (SPM) as Biomarkers of Periodontal Inflammation</brief_title>
  <official_title>Specialized Pro-resolving Mediators (SPM) as Biomarkers of Periodontal Inflammation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sharjah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sharjah</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Periodontal diseases are a public health burden in all countries. Hence, Periodontitis is the&#xD;
      sixth-most prevalent disease in the world, the most common bone diseases in human and the&#xD;
      primary cause for tooth loss in adults leading to significant economic and medical&#xD;
      consequences. All disease biomarkers could help to stratify the general population with those&#xD;
      at high risk of periodontitis and to enroll them in a rigorous prevention program. Advanced&#xD;
      periodontitis has been shown to reduce the quality of life of patients and developing novel&#xD;
      biological monitoring protocols will reduce the prevalence of advanced forms of the disease.&#xD;
&#xD;
      There are alot of research explaining the different types of inflammatory mediators that&#xD;
      could be found in periodontitis patients. But there are a few research have been talking&#xD;
      about lipoxin A4 as an inflammatory biomarker that could detect the effect of non surgical&#xD;
      periodontal therapy effect on the periodontal health.&#xD;
&#xD;
      And the aim of the study is to assess the effect of this non surgical periodontal therapy on&#xD;
      the periodontal health by assessing the concentration of this biomarker.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2022</start_date>
  <completion_date type="Anticipated">June 2024</completion_date>
  <primary_completion_date type="Anticipated">October 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lipoxin A4</measure>
    <time_frame>2 months</time_frame>
    <description>Gingival crevicular fluid concentration</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Inflammation</condition>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Periodontitis patients that will be treatyed with Non surgical Periodontal Therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Periodontally healthy patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Non surgical periodontal therapy</intervention_name>
    <description>Manual root planning+Ultrasonic subgingival debridement</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Control group : Patients diagnosed as periodontally healthy&#xD;
&#xD;
          -  Test group:&#xD;
&#xD;
               -  Patients diagnosed with generalized periodontitis (Stage 3/4, Grade a,b or c).&#xD;
&#xD;
               -  Having at least 15 remaining teeth.&#xD;
&#xD;
               -  Mentally able to understand the communication and to express an informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Systemic diseases with known effect on periodontal health&#xD;
&#xD;
          -  Antibiotics/Anti-inflammatory drugs taken in the last month&#xD;
&#xD;
          -  Women with suspected/known pregnancy, or taking any hormone-based treatment&#xD;
&#xD;
          -  Patients suffering from Xerostomia.&#xD;
&#xD;
          -  Patients smoking more than 20 cig/day.&#xD;
&#xD;
          -  Previous periodontal therapy in the last 3-6 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prof. Zahi Badran, Phd</last_name>
    <role>Study Director</role>
    <affiliation>University of Sharjah</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Prof. Zahi BADRAN, PhD</last_name>
    <phone>+97165057353</phone>
    <email>zbadran@sharjah.ac.ae</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Dental Hospital Sharjah</name>
      <address>
        <city>Sharjah</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zahi BADRAN</last_name>
      <email>zbadran@sharjah.ac.ae</email>
    </contact>
  </location>
  <location_countries>
    <country>United Arab Emirates</country>
  </location_countries>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>January 21, 2023</study_first_submitted>
  <study_first_submitted_qc>January 21, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2023</study_first_posted>
  <last_update_submitted>January 21, 2023</last_update_submitted>
  <last_update_submitted_qc>January 21, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sharjah</investigator_affiliation>
    <investigator_full_name>Zahi BADRAN</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

